---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- Selective Norepinephrine Reuptake Inhibitor (NRI)

**Mechanism of Action (MOA):**
- Inhibits the reuptake of norepinephrine, increasing its levels in the synaptic cleft, which is thought to contribute to its therapeutic effects in ADHD.

**Indications/Uses:**
- Attention Deficit Hyperactivity Disorder (ADHD)

**Side Effects:**
- Decreased appetite
- Nausea
- Vomiting
- Fatigue
- Dizziness

**Adverse Effects:**
- Suicidal ideation in children and adolescents
- Liver injury
- Hypertension
- Tachycardia

**Nursing Teaching and Implications:**
- Educate about the potential for suicidal thoughts and the need for monitoring.
- Advise taking the medication at the same time each day, with or without food.
- Monitor growth in children and adolescents.
- Regularly assess cardiovascular status.

**Contraindications:**
- Severe cardiovascular disorders
- Use within 14 days of MAO inhibitors
- Known hypersensitivity to atomoxetine